Suivant

Lecture automatique

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

0 Vues • 07/04/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

Earn CME for related activities: https://www.naccme.com/oln

This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.

© 2018 NACCME, an HMP Company

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique